Clinical Trials › NCT04650321
RecruitingPhase 4
Home Based Infusions for Ocrelizumab
Sponsored by University of Colorado, Denver
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 110
Target enrollment
1
U.S. states
Mar 2021
Start date
Aug 2021
Expected completion
Interventions / Treatments
Ocrelizumab at home
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Colorado1 site
Centennial
MS centers in Colorado
Compare treatment centers near a trial site by center type, providers and trials.
View Colorado centers